Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Rafael Holdings Inc RFL

Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. It holds a majority equity interest in LipoMedix Pharmaceuticals Ltd. (a clinical-stage pharmaceutical company), Barer Institute Inc. (a preclinical cancer metabolism research operation), and a majority interest in... see more

Bullboard (NYSE:RFL)

View:
Post by whytestockson Sep 23, 2024 8:00pm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEC

JUST IN: $RFL SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DECA, PWUP, MNTX, RFL on Behalf of ShareholdersNEW YORK, NY / ACCESSWIRE / September 23, 2024 / Halper Sadeh LLC, an investor ...more  
Post by AviseAnalyticson Nov 29, 2021 6:49am

5 REASONS WHY RAFAEL HOLDINGS IS A RISKY INVESTMENT!

$RFL   Rafael Holdings Inc, whose subsidiaries include Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd, has announced a realignment of the management team.    The ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities